243 related articles for article (PubMed ID: 29966296)
21. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
[TBL] [Abstract][Full Text] [Related]
22. Click-Free Synthesis of a Multivalent Tricyclic Peptide as a Molecular Transporter.
Kumar S; Mandal D; El-Mowafi SA; Mozaffari S; Tiwari RK; Parang K
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899170
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
24. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin.
Shirazi AN; El-Sayed NS; Tiwari RK; Tavakoli K; Parang K
Curr Drug Deliv; 2016; 13(3):409-17. PubMed ID: 26511089
[TBL] [Abstract][Full Text] [Related]
25. Developing and Testing Methylated Nano-Structured Dipeptides that Inhibit Src Kinase Activity In Vitro for Anti-Cancer Applications.
Nahhas AF; Nahhas AF; Webster TJ
J Vis Exp; 2022 Nov; (189):. PubMed ID: 36533825
[TBL] [Abstract][Full Text] [Related]
26. Characterization of low-abundance species in the active pharmaceutical ingredient of CIGB-300: A clinical-grade anticancer synthetic peptide.
Garay H; Espinosa LA; Perera Y; Sánchez A; Diago D; Perea SE; Besada V; Reyes O; González LJ
J Pept Sci; 2018 Jun; 24(6):e3081. PubMed ID: 29676523
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter.
El-Sayed NS; Shirazi AN; El-Meligy MG; El-Ziaty AK; Nagieb ZA; Parang K; Tiwari RK
Int J Biol Macromol; 2016 Jun; 87():611-22. PubMed ID: 26976071
[TBL] [Abstract][Full Text] [Related]
28. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
[TBL] [Abstract][Full Text] [Related]
29. Lauroylated Histidine-Enriched S4
Morais CM; Cardoso AM; Aguiar L; Vale N; Nóbrega C; Zuzarte M; Gomes P; Pedroso de Lima MC; Jurado AS
Pharm Res; 2020 Sep; 37(10):188. PubMed ID: 32888084
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
Trinh TB; Upadhyaya P; Qian Z; Pei D
ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity.
Mohammadi S; Zakeri-Milani P; Golkar N; Farkhani SM; Shirani A; Shahbazi Mojarrad J; Nokhodchi A; Valizadeh H
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1572-1585. PubMed ID: 28933182
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, and biological activity of poly(arginine)-derived cancer-targeting peptides in HepG2 liver cancer cells.
Joseph SC; Blackman BA; Kelly ML; Phillips M; Beaury MW; Martinez I; Parronchi CJ; Bitsaktsis C; Blake AD; Sabatino D
J Pept Sci; 2014 Sep; 20(9):736-45. PubMed ID: 24931620
[TBL] [Abstract][Full Text] [Related]
33. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
[TBL] [Abstract][Full Text] [Related]
34. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
35. Structure-based design, synthesis and anticancer effect of cyclic Smac-polyarginine peptides.
Khalily MP; Gerekçi S; Güleç EA; Özen C; Özçubukçu S
Amino Acids; 2018 Nov; 50(11):1607-1616. PubMed ID: 30123940
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I
ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402
[TBL] [Abstract][Full Text] [Related]
38. Poly-L-arginine: Enhancing Cytotoxicity and Cellular Uptake of Doxorubicin and Necrotic Cell Death.
Movafegh B; Jalal R; Mohammadi Z; Aldaghi SA
Anticancer Agents Med Chem; 2018; 18(10):1448-1456. PubMed ID: 29651964
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides.
Ye G; Nam NH; Kumar A; Saleh A; Shenoy DB; Amiji MM; Lin X; Sun G; Parang K
J Med Chem; 2007 Jul; 50(15):3604-17. PubMed ID: 17580848
[TBL] [Abstract][Full Text] [Related]
40. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
